Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk

Publication files not online:

Author: Pedersen, G.S. · Hogervorst, J.G.F. · Schouten, L.J. · Konings, E.J.M. · Goldbohm, R.A. · Brandt, P.A. van den
Type:article
Date:2010
Institution: TNO Kwaliteit van Leven
Source:Breast Cancer Research and Treatment, 1, 122, 199-210
Identifier: 364399
Keywords: Biology · Biomedical Research · Acrylamide · Breast cancer · Diet · Estrogen receptor · Progesterone receptor · acrylamide · estrogen receptor · progesterone receptor · adult · aged · article · breast cancer · cancer risk · carcinogenic activity · cohort analysis · controlled study · dietary intake · disease association · female · follow up · food contamination · human · major clinical study · Netherlands · postmenopause · priority journal · protein expression · smoking

Abstract

Acrylamide, a potential human carcinogen, has been discovered in a variety of heat-treated carbohydrate-rich food products. Previously, dietary acrylamide intake was shown to be associated with endocrine-related cancers in humans. We assessed the association between dietary acrylamide intake and risk of postmenopausal breast cancer stratified by estrogen and progesterone receptor status. This study was embedded within the Netherlands Cohort Study on diet and cancer, which was initiated in 1986 enrolling 62,573 women aged 55-69 years at baseline. After 13.3 years of follow-up, 2225 incident breast cancer cases were ascertained, with hormone receptor status information for 43%. Cox proportional hazards analysis was applied to determine hazard ratios in quintiles of dietary acrylamide intake stratifying on estrogen receptor (ER) and progesterone receptor (PR) and smoking status. No association was observed for overall breast cancer or receptor-negative breast cancer risk, irrespective of smoking status. A statistically non-significantly increased risk of ER positive, PR positive and joint receptor-positive breast cancer was found in never-smoking women. The multivariable-adjusted hazard ratios were 1.31 (95% CI: 0.87-1.97, P <sub>trend</sub> = 0.26) for ER+, 1.47 (0.86-2.51, P <sub>trend</sub> = 0.14) for PR+, and 1.43 (0.83-2.46, P <sub>trend</sub> = 0.16) for ER+PR+, when comparing women in the highest quintile of acrylamide intake (median 36.8 μg/day) to women in the lowest (median 9.5 μg/day). This study showed some indications of a positive association between dietary acrylamide intake and receptor-positive breast cancer risk in postmenopausal never-smoking women. Further studies are needed to confirm or refute our observations. © 2009 Springer Science+Business Media, LLC.